Use of pregnancy-compatible medication and control of disease activity with lower glucocorticoid doses in PM/DM pregnancies may be important to achieve good pregnancy outcomes. Abs 0952 #ACR22 @RheumNow https://t.co/LMfebb4GE1 https://t.co/0gYG245BXV
Links:
Pregnancy Course and Outcomes of Patients with Polymyositis and Dermatomyositis…
http://ow.ly/Wo2Q50Ly4bF
13-11-2022
